| | | | | By Joseph Weiford | When clinical supply decisions face uncertainty, speed alone is not enough. Learn how governance frameworks create faster, more secure, and defensible actions. | |
|
| | By PharmaSource | U.S. funding cuts could leave 75 million children without routine vaccines. Five supply chain leaders explain what resilience actually requires and what's at stake if the sector fails to act. | |
|
| | A conversation with Erica Olson, Gilead Sciences | Strong supplier partnerships are the backbone of reliable clinical trial supply, driving speed, flexibility, and better outcomes through trust, transparency, and shared goals. | |
|
| | | |
|
|